UK markets open in 7 hours 8 minutes

Y-mAbs Therapeutics, Inc. (YMAB)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
17.25+0.76 (+4.61%)
At close: 04:00PM EDT
17.21 -0.04 (-0.23%)
After hours: 06:57PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-21,427
-21,427
-95,568
-55,275
-119,337
Depreciation & amortisation
735
735
839
782
396
Stock-based compensation
14,453
14,453
25,602
19,334
16,135
Change in working capital
-19,734
-19,734
-10,371
-7,284
3,444
Accounts receivable
-9,923
-9,923
-4,819
-7,712
0
Inventory
1,637
1,637
-1,190
-5,512
0
Accounts payable
-6,856
-6,856
-919
4,180
852
Other working capital
-27,232
-27,232
-75,921
-103,523
-91,406
Other non-cash items
-
-
-
-62,010
8,707
Net cash provided by operating activities
-27,232
-27,232
-75,921
-102,556
-91,231
Cash flows from investing activities
Investments in property, plant and equipment
-
-
-
-967
-175
Other investing activities
-
-
-
62,010
-2,610
Net cash used for investing activities
0
0
0
61,043
-2,785
Cash flows from financing activities
Common stock issued
-
-
0
107,725
0
Net cash used provided by (used for) financing activities
100
100
84
108,314
2,004
Net change in cash
-27,125
-27,125
-75,802
66,930
-92,502
Cash at beginning of period
105,762
105,762
181,564
114,634
207,136
Cash at end of period
78,637
78,637
105,762
181,564
114,634
Free cash flow
Operating cash flow
-27,232
-27,232
-75,921
-102,556
-91,231
Capital expenditure
-
-
-
-967
-175
Free cash flow
-27,232
-27,232
-75,921
-103,523
-91,406